找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Histone Deacetylase Inhibitors — Epidrugs for Neurological Disorders; Shabir Ahmad Ganai Book 2019 Springer Nature Singapore Pte Ltd. 2019

[復(fù)制鏈接]
樓主: Radiofrequency
21#
發(fā)表于 2025-3-25 05:06:59 | 只看該作者
Epigenetics and its Implications in Neurological Disorders,tions of histone and non-histone substrates. Epigenetic dysregulation due to aberrant activity of these players alters homeostasis provoking neurological complications. Here I discuss the amendments of the definition of epigenetics over time and the various post-translational modifications that hist
22#
發(fā)表于 2025-3-25 09:23:09 | 只看該作者
Epigenetic Enzymes and Drawbacks of Conventional Therapeutic Regimens, acetylation, methylation, phosphorylation etc. Methylation of DNA cytosine is also regarded as epigenetic modifications as it causes gene repression by recruiting HDACs. This chapter gives the bird’s eye view of writers and erasers of epigenetic modifications. Among the writers, special emphasis ha
23#
發(fā)表于 2025-3-25 15:12:22 | 只看該作者
24#
發(fā)表于 2025-3-25 19:15:31 | 只看該作者
25#
發(fā)表于 2025-3-25 22:42:41 | 只看該作者
HDAC Inhibitors as Novel Therapeutic Option Against Therapeutically Challenging Neurological Disordulation and as such are emerging as promising therapeutic agents for vanquishing neurological disorders. Here we discuss the marvellous therapeutic effect of various HDACi against neurological disorders including Alzheimer’s disease, Parkinson’s disease, and epilepsy. The underlying molecular player
26#
發(fā)表于 2025-3-26 02:27:31 | 只看該作者
27#
發(fā)表于 2025-3-26 07:28:35 | 只看該作者
28#
發(fā)表于 2025-3-26 09:05:44 | 只看該作者
29#
發(fā)表于 2025-3-26 16:36:01 | 只看該作者
Future Directions, a particular neurological complication, neuronal death or damage is not general, but specific brain regions are particularly affected. Different focal pathologies are exhibited by distinct disorders, and thus gaining insights regarding the region-specific effects of these inhibitors is requisite fo
30#
發(fā)表于 2025-3-26 17:05:27 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
和硕县| 西林县| 古丈县| 鄂州市| 榆中县| 泰州市| 临武县| 岗巴县| 信阳市| 新竹县| 芷江| 绍兴县| 房山区| 开鲁县| 蒙自县| 日土县| 东乡县| 钟山县| 海原县| 色达县| 蛟河市| 阿鲁科尔沁旗| 牟定县| 富蕴县| 金溪县| 枣阳市| 全州县| 亚东县| 兰州市| 镇康县| 张家口市| 德惠市| 平泉县| 晋州市| 凤阳县| 阳春市| 中山市| 荔波县| 浙江省| 绥芬河市| 涡阳县|